why choose us

Clinical Trials Search

Showing 7,240 of 132,085 result(s)
A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis

Status: Completed

Condition: Plaque Psoriasis

Interventions: Oral tablet

Date: 2023-10-12

Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET)

Status: Completed

Condition: Essential Tremor

Interventions: Once daily oral treatment with titration

Date: 2023-10-12

Autologous Blood Patch for Primary Spontaneous Pneumothorax

Status: Completed

Condition: Primary Spontaneous Pneumothorax

Interventions: 2 ml;kg of whole blood (max 100 ml) is obtained via venipuncture.
This blood is then injected via the chest tube which will then be clamped

Date: 2023-10-12

MCG Discovery Study in Emergency Departments

Status: Completed

Condition: ACS - Acute Coronary Syndrome

Interventions: unshielded device measuring cardiac magnetic fields

Date: 2023-10-12

App for Reducing Cravings to Smoke

Status: Completed

Condition: Smoking

Interventions: Participants will be asked to use a recently developed study smartphone application to reduce cravings to smoke for a 1-week period.
Through the

Date: 2023-10-12

Continuous Glucose Monitoring System Feasibility in Youth With T2D

Status: NOT_YET_RECRUITING

Condition: Type 2 Diabetes

Interventions: Continuous Glucose Monitor System for people with Type 2 Diabetes

Date: 2023-10-12

A Pilot Factorial Trial of an Integrated Lifestyle Intervention

Status: NOT_YET_RECRUITING

Condition: Physical Inactivity

Interventions: The PreventT2 curriculum is based on the original 2002 Diabetes Prevention Prevention (DPP) trial and follow-up studies.
It promotes modest weigh

Date: 2023-10-12

Reducing Silica Exposure Among Brick Kiln Workers in Nepal

Status: NOT_YET_RECRUITING

Condition: Silicosis

Interventions: The participants in this group will be provided with N95 respirator masks to protect from dust and debris while working in the brick kiln and trained

Date: 2023-10-12

Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With NRT

Status: NOT_YET_RECRUITING

Condition: Smoking Cessation

Interventions: 21mg nicotine patch daily; maximum usage 9 weeks

Date: 2023-10-12

The Effects of Zinc Di-(Dibutyryl Lisinate) on Skin Health and the Skin Microbiome in Photoaged Skin

Status: NOT_YET_RECRUITING

Condition: Photoaging

Interventions: Instructions: Apply to the entire face twice daily - morning and evening

Date: 2023-10-12